Okayama nephrotic syndrome treatment group: Study group for short-term combination therapy of angiotensin-2 receptor blocker and cyclosporine for keeping remissio
Not Applicable
- Conditions
- Minimal change nephrotic syndrome
- Registration Number
- JPRN-UMIN000000621
- Lead Sponsor
- Department of Medicine and Clinical Science, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1) Renal dysfunction (Ccr under 30 ml/min) 2) Histry of taking immunosuppressant within one month 3) Patients with malignant disease 4) Malabsorption syndrome or epilepsy 5) Severe heart, liver, or pancreatic disaese 6) Active infectious disease 7) Pregnancy 8) Hypersensitivity to cyclosporin 9) Hypersensitivity to ARB 10) Patients with FSGS 11) Others
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method